News
The company’s lead product candidate is the Deltacel-01, which is in Phase 1 clinical trial, in combination with low-dose targeted radiation for patients with non-small cell lung cancer.
1d
Irish Independent on MSNLive updates: Netanyahu says more Israeli attacks on Iran ‘on the way’ as retaliatory missiles interceptedIsrael indicated it would next set its sights on the enrichment facility known as Fordo, Iran’s second-largest and most ...
Iran’s supreme leader, Ayatollah Ali Khamenei, has replaced two top military commanders killed in a wave of Israeli strikes ...
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics ... including surgery or radiation. The company is also developing ...
4d
Interesting Engineering on MSNNuclear disaster-struck Chernobyl could be turned into sustainable tourism hub after warUkraine signs new agreement to revive Chernobyl and Slavutych as global tourism and education hubs post the war.
In the ruling, Judge Matthew J. Maddox of the Federal District Court in Maryland said that the law only allowed Mr. Trump to ...
France is doubling down on nuclear energy. Once a symbol of national pride and now the backbone of its decarbonized ...
A black hole has blasted out a surprisingly powerful jet in the distant universe, according to a new study from NASA's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results